A Los Angeles jury has awarded $40 million to two women who claim Johnson & Johnson's talcum powder caused their ovarian ...

A California jury on Friday awarded $40 million to two women who said Johnson & Johnson’s baby powder was to blame for their ...

Johnson & Johnson's organic growth and margin expansion remain moderate. Read why I would not add fresh capital to JNJ stock ...

Johnson & Johnson's Rybrevant Faspro was approved as a treatment for people with lung cancer by the Food and Drug Administration. Rybrevant Faspro was approved across all indications for subcutaneous ...

A jury awarded $40 million to two women who claimed that talcum powder made by Johnson & Johnson caused their ovarian cancer.

A Los Angeles jury ordered Johnson & Johnson to pay $966 million to the family of a woman who died from mesothelioma, finding the company liable in the latest trial alleging its talc products cause ...

FDA approves Johnson & Johnson's Akeega combo for BRCA2 metastatic prostate cancer after Phase 3 data showed major reductions in progression risk.

BofA raised Johnson & Johnson's price target to $220, citing steady growth, but sees limited upside from its pipeline through ...

Johnson & Johnson was ordered to pay $966 million to the family of a woman who alleged the New Brunswick-headquartered health giant’s talcum-based baby powder gave her a fatal cancer. Following a ...

Johnson & Johnson’s failed attempts to resolve a mountain of talcum powder lawsuits through class-action bankruptcy settlements have left the company with the daunting prospect of litigating cases ...

Texas Attorney General Ken Paxton announced he is suing the makers of Tylenol, claiming the companies failed to warn consumers about the risks of taking the drug while pregnant. Paxton filed a lawsuit ...